Evaluation of 9 rapid diagnostic tests for screening HIV infection, in Lomé, Togo Performance de 9 tests rapides de diagnostic de l'infection VIH, à Lomé, Togo

Purpose. – HIV rapid diagnostic tests (RDT) could be greatly contributive for a universal access to HIV diagnosis. However, according to the WHO, these tests need to be assessed before they can be used in routine. Method and results. – We assessed 9 RDT in routine clinical use between 2009 and 2013. The sensitivity and specificity observed for 7 tests were ≥ 99% and ≥ 98%, respectively: FIRST RESPONSE HIV1-2-O PMC Medical, India, GENIE Fast HIV 1-2 and GENIE TM III HIV 1/2 Bio-Rad, France, HIV TRI-DOT + Ag; J. Mitra, INDIA; SD BIOLINE HIV 1/2 3.0 and SD BIOLINE HIV/SYPHILIS DUO Standard Diagnostic, Korea; and VIKIA HIV 1/2 ; BioMerieux, France. Two tests had performances inferior to WHO recommendations: INSTI HIV1/2 Biolytical Canada;